Presenters
Medicine at the University of Toronto
Prof. Alice Cheng
Course details
Glucose control therapy is no longer the sole focus when treating T2D, patients with T2D should be supported by both Organ reducing therapy and a multi-risk factor approach as both are not competitive but complementary.
Estimated time to completion: 24 mins & 51 secs.
PC-ZA-101709